Research Article
Quality and Brands of Amoxicillin Formulations in Nairobi, Kenya
Table 8
Summary of content determination and dissolution test for samples from the same manufacturers but differing in quality.
| Sample code | Origin | Sample type | Labelled active ingredients (mg) | Summary | Potency determination | Dissolution test |
| KAY56 | India | Capsule | 500 | Complied | Complied | KAY43 | Amoxicillin oral suspension | 125 | Complied | N/A | KAN95 | Amoxicillin/clavulanic acid tablets | 375 | Complied | Complied | CBD133 | Amoxicillin/clavulanic acid oral suspension | 228 | Failed | N/A |
| KBR63 | India | Amoxicillin oral suspension | 125 | Complied | N/A | SC08 | Amoxicillin/clavulanic acid oral suspension | 228 | Failed | N/A |
| KAY42 | China | Capsule | 500 | Complied | Failed | KAY52 | Capsule | 250 | Complied | Complied |
| KRN93 | Canada | Amoxicillin/clavulanic acid oral suspension | 457 | Complied | N/A | SC03 | India | Amoxicillin oral suspension | 125 | Failed | N/A | CBD128 | New Zealand | Capsule | 500 | Complied | Complied | SC13 | France | Capsule | 500 | Complied | Complied | KRN94 | Mexico | Capsule | 500 | Complied | Complied |
|
|
N/A: not applicable.
|